Our Vision

Biotest is committed to its responsibility to manufacture and market vital medicines from human blood plasma with the HIGHEST SAFETY, QUALITY and EFFICIENCY in a CLIMATE-FRIENDLY WAY, while providing sustainable benefits to society, patients, employees and shareholders on our path to carbon neutrality by 2035.

Sustainability Strategy of Biotest AG

In times of climate change, sustainable management has become enormously important for companies and is becoming more and more important at Biotest, as ESG (Environmental-Social-Governance) criteria are playing an increasingly important role in a wide variety of areas, such as stakeholder decisions regarding investments, the granting of a loan or the choice of employer. The preparation of the Sustainability Report (incl. the EU taxonomy from 2021) is therefore of elementary importance.

The sustainability manager develops, formulates and evaluates an ESG (Environmental, Social and Governance) strategy for the company together with the board of directors and finally implements it holistically in the corporate strategy and structures.